Ambu AuraGain Laryngeal Mask Airway and I-gel in Children

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

94 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-06-12

Study Completion Date

2018-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Children aged below 7 years are randomly assigned to AuraGain Group or I-gel group. After anesthetic induction, AuraGain or I-gel is inserted and mechanical ventilation is started. Oropharyngeal leak pressure, peak inspiratory pressure, success rate for insertion, ease for insertion, ease for gastric tube insertion and fiberoptic bronchoscopic views will be compared between two groups.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Comparison of Ambu® AuraGain™ Laryngeal Mask Airway and I-gel in Adult

NCT03544749

Laryngeal Mask Intubation; Difficult or Failed

COMPLETED NA

The Influence of Head and Neck Position on Performance of Ambu AuraGainTM in Children

NCT03127683

General Anesthesia

COMPLETED NA

Comparing Between Air-Q Intubating Laryngeal Airway and Ambu® AuraGain™

NCT03130413

General Anaesthesia

COMPLETED NA

Ambu AuraOnce Versus Ambu AuraGain LM in Children

NCT02811042

Airway Management

UNKNOWN NA

Distance From the Glottis to the Grille in Children

NCT03156166

General Anesthesia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

General Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AuraGain group

AuraGain is inserted for maintenance of general anesthesia. The size 1 is for children \<5kg, size 2 for 5-10kg, size 2 for 10-20kg, and size 2.5 for 20-30kg.

Group Type EXPERIMENTAL

AuraGain

Intervention Type DEVICE

After anesthetic induction, AuraGain is inserted in children

I-gel group

I-gel is s inserted for maintenance of general anesthesia. The size 1 is for children weighted 2-5kg, size 2 for 5-12kg, size 2 for 10-25kg, and size 2.5 for 25-35kg.

Group Type EXPERIMENTAL

I-gel

Intervention Type DEVICE

After anesthetic induction, I-gel is inserted in children

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AuraGain

After anesthetic induction, AuraGain is inserted in children

Intervention Type DEVICE

I-gel

After anesthetic induction, I-gel is inserted in children

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Ambu AuraGain I-gel supraglottic airway

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children \< 7 years old who scheduled for general anesthesia using supraglottic airway

Exclusion Criteria

* Children who require tracheal intubation
* Emergency operation without nil per os
* History of C-spine surgery or disease
* History of Esophageal disease or surgery

Maximum Eligible Age

7 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes